Concourse Financial Group Securities’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10876 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 11156 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 11066 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10913 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10935 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 11066 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 11108 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 11188 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 10808 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 11081 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 10894 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 10672 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 10426 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 9966 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 9240 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8688 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 8096 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7433 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7109 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6899 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6775 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6682 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6519 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6483 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6332 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6248 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6081 |
|